BeOne Medicines Ltd. (NASDAQ:ONC) is held by 278 institutional investors per 13F filings through March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 8,799,053 | 0 | 0.00% | $2,613,054,769.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 31 Mar, 2026 | 4,975,181 | -5,400 | -0.11% | $1,477,479,502.00 |
| Capital International Investors | 31 Mar, 2026 | 4,158,726 | -955,140 | -18.68% | $1,231,236,530.00 |
| FMR LLC | 31 Mar, 2026 | 3,693,610 | -299,017 | -7.49% | $1,096,891,494.00 |
| Capital World Investors | 31 Mar, 2026 | 1,622,687 | 1,622,687 | 0.00% | $481,889,358.00 |
| HHLR ADVISORS, LTD. | 31 Mar, 2026 | 1,034,306 | 0 | 0.00% | $307,157,853.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,032,298 | 498,781 | 93.49% | $306,561,537.00 |
| Temasek Holdings (Private) Ltd | 31 Mar, 2026 | 862,643 | -56,944 | -6.19% | $256,179,092.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 657,501 | -18,709 | -2.77% | $195,258,096.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 539,769 | 539,769 | 0.00% | $160,297.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 465,000 | -35,000 | -7.00% | $138,091,050.00 |
| Morgan Stanley | 31 Mar, 2026 | 464,472 | 26,811 | 6.13% | $137,934,923.00 |
| UBS Group AG | 31 Mar, 2026 | 415,330 | 263,243 | 173.09% | $123,340,550.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 405,273 | 26,441 | 6.98% | $120,353,804.00 |
| Baird Financial Group, Inc. | 31 Mar, 2026 | 349,651 | 45,312 | 14.89% | $103,836,007.00 |
| Capital International, Inc./CA/ | 31 Mar, 2026 | 302,243 | -5,417 | -1.76% | $89,757,104.00 |
| Candriam S.C.A. | 31 Mar, 2026 | 259,731 | 62,470 | 31.67% | $77,132,315.00 |
| Man Group plc | 31 Mar, 2026 | 241,922 | -6,592 | -2.65% | $71,843,576.00 |
| FIRST TRUST ADVISORS LP | 31 Mar, 2026 | 241,426 | 115,601 | 91.87% | $71,696,279.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 204,846 | 173,395 | 551.32% | $60,833,117.00 |